Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;179(8):1544-1564.
doi: 10.1111/bph.15481. Epub 2021 May 21.

Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects

Affiliations
Review

Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects

Mariana Rae et al. Br J Pharmacol. 2022 Apr.

Abstract

Oxytocin (OT) and vasopressin (AVP) are endogenous ligands for OT and AVP receptors in the brain and in the peripheral system. Several studies demonstrate that OT and AVP have opposite roles in modulating stress, anxiety and social behaviours. Interestingly, both peptides and their receptors exhibit high sequence homology which could account for the biased signalling interaction of the peptides with OT and AVP receptors. However, how and under which conditions this crosstalk occurs in vivo remains unclear. In this review we shed light on the complexity of the roles of OT and AVP, by focusing on their signalling and behavioural differences and exploring the crosstalk between the receptor systems. Moreover, we discuss the potential of OT and AVP receptors as therapeutic targets to treat human disorders, such as autism, schizophrenia and drug abuse. LINKED ARTICLES: This article is part of a themed issue on Building Bridges in Neuropharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.8/issuetoc.

Keywords: GPCR; anxiety; crosstalk; oxytocin; social behaviour; substance use disorder; vasopressin.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Amino acid sequences of human oxytocin and vasopressin neuropeptides (a) and their receptors (b). (a) Primary sequence of oxytocin and vasopressin in single letter amino acid code. (b) Primary sequence of human OT receptors (OTR), and V1A (AVPR1a), V1B (AVPR1b) and V2 (AVPR2) receptors. The amino acid residues that have been described to interact with the endogenous ligands vasopressin (AVP) and oxytocin (OT), as well as the co-factors Mg2+ and cholesterol (Ct) are highlighted by the dashed rectangles. Amino acids in bold represent residues that are conserved in the OT, V1A, V1B and V2 receptors. * marks residues that are conserved among all the receptors. # marks residues that are conserved among OT, V1A and V1B receptors.: marks residues that have same functional groups. Blue represents amino acids with negative charged side chain; magenta represents residues with positive charge; green represents residues with polar uncharged side chain; purple represents residues with hydrophobic side chain. OTR, oxytocin receptor; V1A, V1B and V2, subtypes of vasopressin receptors; TM, transmembrane; EL, extracellular loop; IL, intracellular loop. Sequence obtained from uniport.org
FIGURE 2
FIGURE 2
Schematic representation of context-dependent modulations of oxytocin and vasopressin. Oxytocin can act on different brain regions depending on the social context, leading to different behavioural outcomes. Expression of V1A receptors (AVPR1a) is modulated by housing or sexual experience, which increases or decreases aggression. CeA, central amygdala; Hyp, hypothalamus; LS, lateral septum; OT, oxytocin; AVP, vasopressin. Figure was generated using information obtained from Albers, 2012; Johnson & Young, 2015; Guzmán et al., 2013
FIGURE 3
FIGURE 3
Behaviours modulated by oxytocin and vasopressin and their potential pharmacotherapeutic applications in autism, schizophrenia and SUD. Intranasal manipulation of oxytocinergic and vasopressinergic systems lead to improvement in symptoms observed in these disorders. Symbols indicate (+) increase or (−) decrease in the respective behaviour. SUD, substance use disorder

Similar articles

Cited by

References

    1. Albers HE (2012). The regulation of social recognition, social communication and aggression: Vasopressin in the social behavior neural network. Hormones and Behavior, 61, 283–292. 10.1016/j.yhbeh.2011.10.007 - DOI - PubMed
    1. Albers HE, Dean A, Karom MC, Smith D, & Huhman KL (2006). Role of V1a vasopressin receptors in the control of aggression in Syrian hamsters. Brain Research, 1073–1074, 425–430. - PubMed
    1. Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA, & CGTP Collaborators. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology, 176, S21–S141. 10.1111/bph.14748 - DOI - PMC - PubMed
    1. Averbeck BB, Bobin T, Evans S, & Shergill SS (2012). Emotion recognition and oxytocin in patients with schizophrenia. Psychological Medicine, 42, 259–266. 10.1017/S0033291711001413 - DOI - PMC - PubMed
    1. Bach P, Reinhard I, Bühler S, Vollstädt-Klein S, Kiefer F, & Koopmann A (2019). Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkers. Psychoneuroendocrinology, 109, 104385. - PubMed

Publication types